The key to healthier weight loss drugs could be found somewhere unexpected: inside a python’s blood. The slithering serpents ...

Khloe Kardashian shared insight into her evolving relationship with food, admitting her divorce from Lamar Odom kickstarted her desire to lose weight and get healthier.

About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 Americans. And the field of weight-loss treatment is on the verge of even more ...

It finally struck me that nothing changes if nothing changes.

Planning for major weight loss may soon become an easier pill − or balloon − to swallow. As manufacturers ramp up for a GLP-1 legal battle and every food brand seems to be releasing new protein-packed ...

Novo's drug, CagriSema, didn't achieve its key goal of demonstrating non-inferiority on weight loss when compared to Eli Lilly's rival drug tirzepatide. The stock plummeted on Monday, hitting its ...

CagriSema shows 23% weight loss versus 25.5% for Zepbound Novo's shares drop 15% Lilly's shares rise 4% in US pre-market trading Outcome is 'worst-case scenario' for Novo, investor says Few analysts ...

Novo Nordisk, the Danish drugmaker behind blockbuster weight-loss drugs Ozempic and Wegovy, is losing ground to rival Eli Lilly. On Monday, Novo announced that its next-generation weight-loss ...

Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo Nordisk in the obesity drug race. While Novo’s shares have struggled this ...